Cargando…

Epitope Mapping Immunoassay Analysis of the Interaction between β-Amyloid and Fibrinogen

The vast majority of patients with Alzheimer’s disease (AD) suffer from impaired cerebral circulation. Substantial evidence indicates that fibrinogen (Fbg) and fibrin clot formation play an important role in this circulatory dysfunction in AD. Fbg interacts with β-amyloid (1-42) (Aβ), forming plasmi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Giau, Vo, An, Seong Soo A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387197/ https://www.ncbi.nlm.nih.gov/pubmed/30678343 http://dx.doi.org/10.3390/ijms20030496

Ejemplares similares

Characterizing affinity epitopes between prion protein and β-amyloid using an epitope mapping immunoassay
por: Kang, Mino, et al.
Publicado: (2013)

Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
por: Yang, YoungSoon, et al.
Publicado: (2018)

Erratum: Plasma Oligomeric Beta Amyloid in Alzheimer's Disease with History of Agent Orange Exposure
por: Yang, YoungSoon, et al.
Publicado: (2023)

Mapping of citrullinated fibrinogen B-cell epitopes in rheumatoid arthritis by imaging surface plasmon resonance
por: van Beers, Joyce JBC, et al.
Publicado: (2010)

Recent advances in the treatment of pathogenic infections using antibiotics and nano-drug delivery vehicles
por: Van Giau, Vo, et al.
Publicado: (2019)

Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment
por: Giau, Vo Van, et al.
Publicado: (2019)

Transcriptomics in Alzheimer’s Disease: Aspects and Challenges
por: Bagyinszky, Eva, et al.
Publicado: (2020)

COVID-19 Genetic Variants and Their Potential Impact in Vaccine Development
por: Vo, Giau Van, et al.
Publicado: (2022)

Recent advances in the treatment of C. difficile using biotherapeutic agents
por: Giau, Vo Van, et al.
Publicado: (2019)

Analysis of 50 Neurodegenerative Genes in Clinically Diagnosed Early-Onset Alzheimer’s Disease
por: Giau, Vo Van, et al.
Publicado: (2019)

Fully automated and highly specific plasma β-amyloid immunoassays predict β-amyloid status defined by amyloid positron emission tomography with high accuracy
por: Yamashita, Kazuto, et al.
Publicado: (2022)

Role of apolipoprotein E in neurodegenerative diseases
por: Giau, Vo Van, et al.
Publicado: (2015)

Additional diagnostic testing of the 2019 novel coronavirus (SARS-CoV-2)
por: Vo, Van Giau, et al.
Publicado: (2020)

Development of a nanobody-based immunoassay for the sensitive detection of fibrinogen-like protein 1
por: Zhang, Wan-ting, et al.
Publicado: (2021)

Anti-Hepatocellular-Cancer Activity Exerted by β-Sitosterol and β-Sitosterol-Glucoside from Indigofera zollingeriana Miq
por: Vo, Tuong Kha, et al.
Publicado: (2020)

The Correlations Between Plasma Fibrinogen With Amyloid-Beta and Tau Levels in Patients With Alzheimer’s Disease
por: Fan, Dong-Yu, et al.
Publicado: (2021)

Correction to: Plasma Fibrinogen Is a Natural Deterrent to Amyloid β-Induced Platelet Activation and Neuronal Toxicity
por: Sonkar, Vijay K., et al.
Publicado: (2019)

Genome-editing applications of CRISPR–Cas9 to promote in vitro studies of Alzheimer’s disease
por: Giau, Vo Van, et al.
Publicado: (2018)

First amyloid β1‐42 certified reference material for re‐calibrating commercial immunoassays
por: Boulo, Sébastien, et al.
Publicado: (2020)

Detection of Amyloid-β(1–42) Aggregation With a Nanostructured Electrochemical Sandwich Immunoassay Biosensor
por: Wang, Bing-Yu, et al.
Publicado: (2022)

APP, PSEN1, and PSEN2 Mutations in Asian Patients with Early-Onset Alzheimer Disease
por: Giau, Vo Van, et al.
Publicado: (2019)

Genetic Factors of Cerebral Small Vessel Disease and Their Potential Clinical Outcome
por: Giau, Vo Van, et al.
Publicado: (2019)

A pathogenic PSEN2 p.His169Asn mutation associated with early-onset Alzheimer’s disease
por: Giau, Vo Van, et al.
Publicado: (2018)

Characterization of mutations in PRNP (prion) gene and their possible roles in neurodegenerative diseases
por: Bagyinszky, Eva, et al.
Publicado: (2018)

Multimodal Mesoporous Silica Nanocarriers for Dual Stimuli-Responsive Drug Release and Excellent Photothermal Ablation of Cancer Cells
por: Tran, Vy Anh, et al.
Publicado: (2020)

Tailoring Hydrophobic Interactions between Probes and Amyloid-β Peptides for Fluorescent Monitoring of Amyloid-β Aggregation
por: Kim, Sonam, et al.
Publicado: (2018)

Interaction of Fibrinogen with Dextran Sulfate
por: Sasaki, Susumu, et al.
Publicado: (1959)

Bi-Epitope SPR Surfaces: A Solution to Develop Robust Immunoassays
por: Peng, Li, et al.
Publicado: (2014)

Development of Immunoassays for the Quantitative Assessment of Amyloid-β in the Presence of Therapeutic Antibody: Application to Pre-Clinical Studies
por: Bogstedt, Anna, et al.
Publicado: (2015)

Bioinspired Synthesis of ZnO@polydopamine/Au for Label-Free Photoelectrochemical Immunoassay of Amyloid-β Protein
por: He, Guangli, et al.
Publicado: (2021)

Identification of a novel mutation in APP gene in a Thai subject with early-onset Alzheimer’s disease
por: Van Giau, Vo, et al.
Publicado: (2018)

Pathogenic PSEN1 Glu184Gly Mutation in a Family from Thailand with Probable Autosomal Dominant Early Onset Alzheimer’s Disease
por: Senanarong, Vorapun, et al.
Publicado: (2020)

Interactions between Amyloid-β and Hemoglobin: Implications for Amyloid Plaque Formation in Alzheimer's Disease
por: Chuang, Jia-Ying, et al.
Publicado: (2012)

Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status
por: Willemse, Eline A. J., et al.
Publicado: (2021)

Computational Prediction of the Interaction of Ivermectin with Fibrinogen
por: Vottero, Paola, et al.
Publicado: (2023)

Improved fibronectin-immobilized fibrinogen microthreads for the attachment and proliferation of fibroblasts
por: Rajangam, Thanavel, et al.
Publicado: (2013)

GPVI (Glycoprotein VI) Interaction With Fibrinogen Is Mediated by Avidity and the Fibrinogen αC-Region
por: Xu, Rui-Gang, et al.
Publicado: (2021)

Early-onset Alzheimer’s disease patient with prion (PRNP) p.Val180Ile mutation
por: Bagyinszky, Eva, et al.
Publicado: (2019)

A pathogenic PSEN1 Trp165Cys mutation associated with early-onset Alzheimer’s disease
por: Van Giau, Vo, et al.
Publicado: (2019)

Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer’s Disease
por: Giau, Vo Van, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a1qikfijott8qqvk4j9rf86aaf